SI1173418T1 - Kristalna oblika 3 natrijeve soli 5-kloro-2-metoksi-N-(2-(4-metoksi-3-metilaminotiokarbonilamino- sulfonilfenil)etil)benzamida - Google Patents
Kristalna oblika 3 natrijeve soli 5-kloro-2-metoksi-N-(2-(4-metoksi-3-metilaminotiokarbonilamino- sulfonilfenil)etil)benzamidaInfo
- Publication number
- SI1173418T1 SI1173418T1 SI200030775T SI200030775T SI1173418T1 SI 1173418 T1 SI1173418 T1 SI 1173418T1 SI 200030775 T SI200030775 T SI 200030775T SI 200030775 T SI200030775 T SI 200030775T SI 1173418 T1 SI1173418 T1 SI 1173418T1
- Authority
- SI
- Slovenia
- Prior art keywords
- methoxy
- sulfonylphenyl
- benzamide
- chloro
- ethyl
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C335/00—Thioureas, i.e. compounds containing any of the groups, the nitrogen atoms not being part of nitro or nitroso groups
- C07C335/40—Thioureas, i.e. compounds containing any of the groups, the nitrogen atoms not being part of nitro or nitroso groups having nitrogen atoms of thiourea or isothiourea groups further bound to other hetero atoms
- C07C335/42—Sulfonylthioureas; Sulfonylisothioureas
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P41/00—Drugs used in surgical methods, e.g. surgery adjuvants for preventing adhesion or for vitreum substitution
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/06—Antiarrhythmics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Hospice & Palliative Care (AREA)
- Surgery (AREA)
- Urology & Nephrology (AREA)
- Vascular Medicine (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DE19917233A DE19917233A1 (de) | 1999-04-16 | 1999-04-16 | Kristalline Formen des Natriumsalzes des 5-Chlor-2-methoxy-N-(2-(4-methoxy-3-methylaminothiocarbonylaminosulfonyl-phenyl)-ethyl)- benzamids |
PCT/EP2000/002984 WO2000063167A1 (en) | 1999-04-16 | 2000-04-04 | Crystalline forms of the sodium salt of 5- chloro -2- methoxy -n- (2- (4-methoxy -3- methyl aminothio carbonylamino sulfonylphenyl) ethyl) benzamide |
EP00926805A EP1173418B1 (en) | 1999-04-16 | 2000-04-04 | Crystalline form 3 of the sodium salt of 5- chloro -2- methoxy -n- (2- (4-methoxy -3- methyl aminothio carbonylamino sulfonylphenyl) ethyl) benzamide |
Publications (1)
Publication Number | Publication Date |
---|---|
SI1173418T1 true SI1173418T1 (sl) | 2006-02-28 |
Family
ID=7904803
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
SI200030775T SI1173418T1 (sl) | 1999-04-16 | 2000-04-04 | Kristalna oblika 3 natrijeve soli 5-kloro-2-metoksi-N-(2-(4-metoksi-3-metilaminotiokarbonilamino- sulfonilfenil)etil)benzamida |
Country Status (33)
Country | Link |
---|---|
US (1) | US6723751B1 (sl) |
EP (2) | EP1637519B1 (sl) |
JP (1) | JP4662640B2 (sl) |
KR (1) | KR100700302B1 (sl) |
CN (1) | CN1168712C (sl) |
AR (1) | AR023479A1 (sl) |
AT (2) | ATE414059T1 (sl) |
AU (1) | AU773246B2 (sl) |
BR (1) | BR0010658A (sl) |
CA (1) | CA2370388C (sl) |
CZ (1) | CZ302459B6 (sl) |
DE (3) | DE19917233A1 (sl) |
DK (1) | DK1173418T3 (sl) |
EE (1) | EE04612B1 (sl) |
ES (1) | ES2251996T3 (sl) |
HK (1) | HK1046270B (sl) |
HR (1) | HRP20010744B1 (sl) |
HU (1) | HU229082B1 (sl) |
IL (2) | IL145921A0 (sl) |
ME (1) | MEP55708A (sl) |
MX (1) | MXPA01010275A (sl) |
MY (1) | MY122588A (sl) |
NO (1) | NO327798B1 (sl) |
NZ (1) | NZ514788A (sl) |
PL (1) | PL203809B1 (sl) |
RS (1) | RS50916B (sl) |
RU (1) | RU2235089C2 (sl) |
SI (1) | SI1173418T1 (sl) |
SK (1) | SK287175B6 (sl) |
TR (2) | TR200102993T2 (sl) |
TW (1) | TWI276622B (sl) |
WO (1) | WO2000063167A1 (sl) |
ZA (1) | ZA200108400B (sl) |
Families Citing this family (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP2289507A1 (en) * | 2003-03-17 | 2011-03-02 | Japan Tobacco, Inc. | Pharmaceutical compositions of CETP inhibitors |
TWI393560B (zh) * | 2003-05-02 | 2013-04-21 | Japan Tobacco Inc | 包含s-〔2(〔〔1-(2-乙基丁基)環己基〕羰基〕胺基)苯基〕2-甲基丙烷硫酯及hmg輔酶a還原酶抑制劑之組合 |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
ES2098069T3 (es) | 1993-02-23 | 1997-04-16 | Hoechst Ag | Bencenosulfonil-ureas y -tioureas sustituidas, procedimiento para su preparacion y su utilizacion como agentes farmaceuticos. |
DE19505397A1 (de) * | 1995-02-17 | 1996-08-22 | Hoechst Ag | Substituierte Benzolsulfonylharnstoffe und -thioharnstoffe, Verfahren zu ihrer Herstellung, ihre Verwendung als Medikament oder Diagnostikum sowie sie enthaltendes Medikament |
CZ301165B6 (cs) * | 1998-09-10 | 2009-11-25 | Sanofi - Aventis Deutschland GmbH | Použití benzensulfonyl(thio)mocovin pro lécení a profylaxi dysfunkcí autonomní nervové soustavy a použití benzensulfonyl(thio)mocovin v kombinaci s beta-receptorovými blokátory |
-
1999
- 1999-04-16 DE DE19917233A patent/DE19917233A1/de not_active Withdrawn
-
2000
- 2000-04-04 ME MEP-557/08A patent/MEP55708A/xx unknown
- 2000-04-04 SK SK1458-2001A patent/SK287175B6/sk not_active IP Right Cessation
- 2000-04-04 AT AT05024254T patent/ATE414059T1/de not_active IP Right Cessation
- 2000-04-04 PL PL351245A patent/PL203809B1/pl unknown
- 2000-04-04 ES ES00926805T patent/ES2251996T3/es not_active Expired - Lifetime
- 2000-04-04 BR BR0010658-5A patent/BR0010658A/pt not_active IP Right Cessation
- 2000-04-04 RU RU2001130886/04A patent/RU2235089C2/ru not_active IP Right Cessation
- 2000-04-04 HU HU0200791A patent/HU229082B1/hu not_active IP Right Cessation
- 2000-04-04 MX MXPA01010275A patent/MXPA01010275A/es active IP Right Grant
- 2000-04-04 NZ NZ514788A patent/NZ514788A/xx not_active IP Right Cessation
- 2000-04-04 DE DE60040811T patent/DE60040811D1/de not_active Expired - Lifetime
- 2000-04-04 TR TR2001/02993T patent/TR200102993T2/xx unknown
- 2000-04-04 EP EP05024254A patent/EP1637519B1/en not_active Expired - Lifetime
- 2000-04-04 TR TR2005/01142T patent/TR200501142T2/xx unknown
- 2000-04-04 CA CA002370388A patent/CA2370388C/en not_active Expired - Fee Related
- 2000-04-04 EE EEP200100532A patent/EE04612B1/xx not_active IP Right Cessation
- 2000-04-04 CN CNB008063184A patent/CN1168712C/zh not_active Expired - Fee Related
- 2000-04-04 WO PCT/EP2000/002984 patent/WO2000063167A1/en active IP Right Grant
- 2000-04-04 IL IL14592100A patent/IL145921A0/xx active IP Right Grant
- 2000-04-04 AT AT00926805T patent/ATE311364T1/de active
- 2000-04-04 SI SI200030775T patent/SI1173418T1/sl unknown
- 2000-04-04 CZ CZ20013672A patent/CZ302459B6/cs not_active IP Right Cessation
- 2000-04-04 DK DK00926805T patent/DK1173418T3/da active
- 2000-04-04 DE DE60024431T patent/DE60024431T2/de not_active Expired - Lifetime
- 2000-04-04 EP EP00926805A patent/EP1173418B1/en not_active Expired - Lifetime
- 2000-04-04 KR KR1020017013220A patent/KR100700302B1/ko not_active IP Right Cessation
- 2000-04-04 JP JP2000612263A patent/JP4662640B2/ja not_active Expired - Fee Related
- 2000-04-04 AU AU45428/00A patent/AU773246B2/en not_active Ceased
- 2000-04-04 RS YUP-720/01A patent/RS50916B/sr unknown
- 2000-04-13 AR ARP000101712A patent/AR023479A1/es not_active Application Discontinuation
- 2000-04-14 US US09/549,538 patent/US6723751B1/en not_active Expired - Lifetime
- 2000-04-14 MY MYPI20001609A patent/MY122588A/en unknown
- 2000-05-10 TW TW089106840A patent/TWI276622B/zh not_active IP Right Cessation
-
2001
- 2001-10-12 ZA ZA200108400A patent/ZA200108400B/xx unknown
- 2001-10-14 IL IL145921A patent/IL145921A/en not_active IP Right Cessation
- 2001-10-15 NO NO20015014A patent/NO327798B1/no not_active IP Right Cessation
- 2001-10-15 HR HR20010744A patent/HRP20010744B1/xx not_active IP Right Cessation
-
2002
- 2002-10-30 HK HK02107874.4A patent/HK1046270B/zh not_active IP Right Cessation
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
HK1026699A1 (en) | Crystalline form of omeprazole sodium salt | |
DK0490689T3 (da) | 3-(2-(Dimethylamino)ethyl)-N-methyl-1H-indol-5-methansulfonamid sulfatsalt (2:1) | |
HUP0202536A3 (en) | Crystals of the sodium salt of pravastatin | |
HUP0204034A3 (en) | Stable salts of novel derivatives of 3,3-diphenylpropylamines | |
HK1041259A1 (en) | Novel crystalline form of the potassium salt of (s)- omeprazole | |
IL146288A0 (en) | Vla-4 inhibitor compounds | |
NO20011083D0 (no) | Krystallinske formler av EtO2C-CH2-(R)Cgl-Aze-Pab-OH | |
HK1053657A1 (en) | Novel heterocyclic compounds and salts thereof andmedicinal use of the same | |
IL110485A (en) | Quaternary salts of para- dialkylamino benzamide derivatives | |
PL331772A1 (en) | Stable non-hygroscopic crystalline form of n-[n-n-(4-piperidin-4-yl)-n-ethylglycin] compounds | |
IL155041A0 (en) | Process for the preparation of n-(substituted phenyl)-3-alkyl-, aryl-and heteroarylsulfonyl-2-hydroxy-2-alkyl-and haloalkylpropanamide compounds | |
SI1173418T1 (sl) | Kristalna oblika 3 natrijeve soli 5-kloro-2-metoksi-N-(2-(4-metoksi-3-metilaminotiokarbonilamino- sulfonilfenil)etil)benzamida | |
HK1035535A1 (en) | Crystalline forms of osanetant | |
PL345542A1 (en) | Novel salts of n-tert-butylhydroxylamine | |
PT1212095E (pt) | Processo para a preparacao de uma formulacao de libertacao retardada | |
FR2801584B1 (fr) | Procede de preparation d'un compose polyaromatique | |
MA26840A1 (fr) | Cristaux d'inhibiteur d'echangeur sodium-hydrogene de type 1 | |
HU9904011D0 (en) | Novel salts of dipeptid derivatives | |
GB2376233B (en) | Crystals of a pharmaceutically acceptable salt of citalopram wherein the median size of the crystals is at least 40 microns | |
NZ240662A (en) | Preparation of the anhydrous crystalline form of fenoxydim | |
FR2826662B1 (fr) | Procede de preparation d'un sel de polyaniline | |
SI0991641T1 (sl) | Kristalinična oblika natrijeve soli omeprazola | |
ZA9810653B (en) | Insecticidal photostable acid salt derivatives of N-benzyl-4-benzhydrolpiperidines | |
IT1303687B1 (it) | Impiego dell'acido gammaidrossibutirrico o di un suo salefarmaceuticamente accettabile per il trattamento dell'ischemia |